Statin use and Alzheimer's - Ozone Chelation - NeuroActive Brain Sustain

Reducing the risk of Alzheimer's.

A study involving a two-year statin exposure period discovered that participants exposed to higher statin levels during that time were 10% less likely to receive a diagnosis of Alzheimer's disease.  The study suggests that although statins may lower risk of developing Alzheimer's, the decrease in risk varies across statin molecules and by gender, race, and ethnicity. High exposure reduces the risk among women of all races, however it has the highest effect in Hispanic men, followed by black women, white women and white men. None of the statins affected the risk for developing Alzheimer's in  black men in the study.

We recognize elevated heavy metals that cross the blood brain barrier as risk factors for Alzheimer disease. We test and treat heavy metal toxicity with I.V. ozone chelation therapy. It's safe, effective, advanced treatment that prevents further damage. All ozone therapies are MD ordered in NYS.  Better Brain Health can be achieved with dietary changes, exercises, drinking plenty of water, and our Better Brain Health I.V. therapies.

Xymogen's NeuroActive Brain Sustain, Chelex and AlaMax Protect are all good choices to protect your brain while Cardio Essentials and CoQmax Ubiquinol are the best alternative choices to statins.

1. True or False. According to study findings, increased statin use was associated with increased risk of Alzheimer’s disease onset.

A. True
B. False

2. The study found that although statins may lower the risk of Alzheimer’s disease onset, the decrease in risk varies by __________.

A. Patient gender
B. Patient ethnicity
C. Statin molecules
D. All of the above

3. True or False. High exposure to statins reduced the risk of Alzheimer’s disease among female patients of all races, according to study findings.

A. True
B. False

 4. According to study findings, statins decreased the risk of Alzheimer’s disease the most among __________.

A. Black women
B. Hispanic men
C. White men
D. White women

5. True or False. According to study findings, statins decreased the risk of Alzheimer’s disease among black men.

A. True
B. False

Alzheimer's Patients Need to Keep Moving

Blueberries and Alzheimer's

Herpes and Alzheimer's

Answer Key:

1. B. False - According to findings of a study involving a two-year statin exposure period, cited in a literature review published online in Neurology Reviews, “study participants who were exposed to higher statin levels during the two-year exposure period were 10% less likely to receive a diagnosis of Alzheimer’s disease during follow-up, compared with those exposed to lower levels of statins.”

2. D. All of the above - According to study findings cited in a literature review published online in Neurology Reviews, “[s]tatins may lower the risk of developing Alzheimer’s disease, but the decrease in risk varies across statin molecules, and by gender, race, and ethnicity.”

3. A. True -According to study findings cited in a literature review published online in Neurology Reviews, “[h]igh exposure to statins reduced the risk of Alzheimer’s disease among women of all races.”

4. B. Hispanic men - According to study findings cited in a literature review published online in Neurology Reviews, “[s]tatins decreased the risk of Alzheimer’s disease the most among Hispanic men…, followed by black women…, white women…, and white men.”

5. B. False - According to study findings cited in a literature review published online in Neurology Reviews, “none of the statins assessed in the study affected the risk of developing Alzheimer’s disease among black men.”